2020
DOI: 10.3934/biophy.2020023
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticle-based delivery platforms for mRNA vaccine development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 98 publications
0
18
0
Order By: Relevance
“…Depending upon the type of mRNA sequence incorporated into the vaccine, this vaccine occurs in 2 types: self-amplifying mRNA vaccine or non-replicating mRNA vaccine 12,14 . The basic components of mRNA incorporated into the vaccine which are common to both the types of mRNA vaccines include a 5' cap, 5' and 3' untranslated regions (UTRs), open reading frame (ORF), and a 3' poly (A) tail 14 .…”
Section: Types Of Mrna Vaccinesmentioning
confidence: 99%
See 2 more Smart Citations
“…Depending upon the type of mRNA sequence incorporated into the vaccine, this vaccine occurs in 2 types: self-amplifying mRNA vaccine or non-replicating mRNA vaccine 12,14 . The basic components of mRNA incorporated into the vaccine which are common to both the types of mRNA vaccines include a 5' cap, 5' and 3' untranslated regions (UTRs), open reading frame (ORF), and a 3' poly (A) tail 14 .…”
Section: Types Of Mrna Vaccinesmentioning
confidence: 99%
“…The synthesized mRNA sequence is sealed at both ends by inserting a cap at its 5' end and a poly (A) tail at its 3' end during the process of in vitro transcription. Capping and tailing of mRNA can also be carried out by enzymatic methods employing guanylyltransferase, 2'-O-methyltransferase, poly-A-polymerase after the mRNA is transcribed 12 . Further, microbeads-based precipitation or high performance liquid chromatography (HPLC) methods are used to remove double-stranded RNA, enzymes, free nucleotides, shortened nucleic acid fragments to purify the mRNA molecule which is then formulated into a drug product 8 .…”
Section: Manufacturing Process Of Mrna Vaccinementioning
confidence: 99%
See 1 more Smart Citation
“…Protamine has the ability to improve the transfection of mRNA, and several protamine mRNA complexes are now being evaluated in clinical trials (NCT02692976) in cancer patients. mRNA-protamine complex encapsulated in poly(ε-caprolactone) (PCL) NPs results in intracellular delivery of mRNA molecules [107]. Various polypeptides can form complexes with nucleic acids and provide a platform for their delivery, they also show a high transfection efficiency [108].…”
Section: Delivery Of Mrnamentioning
confidence: 99%
“…The mechanisms that activate anticancer immunity include a regulation or stimulation of each step in cancer-immunity interactions and are aimed, in particular, at increasing the amounts and functional activities of cytotoxic T cells and natural killers, the production of antibodies in B cells, and cell secretion of cytokines, factors stimulating immune cell proliferation, or factors suppressing the growth of tumor cell clones [19][20][21].…”
Section: Introductionmentioning
confidence: 99%